MyFinsight
Home
Blog
About
Contact
Download
Download image
EXPAREL
$575,130K
(4.77%↑ Y/Y)
ZILRETTA
$116,633K
(-1.23%↓ Y/Y)
Iovera
$24,178K
(5.98%↑ Y/Y)
Bupivacaine Liposome
Injectable Suspension
$6,913K
(-5.59%↓ Y/Y)
Product
$722,854K
Royalty
$3,557K
Total revenues
$726,411K
(3.63%↑ Y/Y)
Income (loss) from
operations
$19,191K
(126.16%↑ Y/Y)
Total operating
expenses
$707,220K
(-8.67%↓ Y/Y)
Income (loss) before
income taxes
$16,874K
(126.74%↑ Y/Y)
Total other (expense)
income, net
-$2,317K
(-122.57%↓ Y/Y)
Interest income
$22,732K
(15.46%↑ Y/Y)
Selling, general and
administrative
$368,759K
(25.39%↑ Y/Y)
Cost of goods sold
$149,749K
(-12.13%↓ Y/Y)
Research and development
$117,312K
(43.81%↑ Y/Y)
Amortization of acquired
intangible assets
$57,288K
(0.00%↑ Y/Y)
Contingent consideration
gains,...
$14,112K
(83.23%↑ Y/Y)
Net income (loss)
$7,034K
(107.07%↑ Y/Y)
Income tax expense
$9,840K
(-73.01%↓ Y/Y)
Interest expense
$17,446K
(5.29%↑ Y/Y)
Other, net
-$6,620K
(-1674.80%↓ Y/Y)
(loss) gain on early
extinguishment of debt
-$983K
(-113.08%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)